Dmitry Balyasny’s Novavax NVAX Stock Holding History

Dmitry Balyasny’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-482,700	Closed	-$3.24M	–	3327
2025 Q4	$3.24M	Sell	482,700 -229,600	-32%	-$1.73M	﹤0.01%	1626
2025 Q3	$6.18M	Buy	712,300 +85,300	+14%	+$664K	0.01%	1274
2025 Q2	$3.95M	Buy	627,000 +492,500	+366%	+$3.26M	0.01%	1397
2025 Q1	$862K	Sell	134,500 -37,200	-22%	-$308K	﹤0.01%	2062
2024 Q4	$1.38M	Buy	171,700 +41,300	+32%	+$398K	﹤0.01%	1815
2024 Q3	$1.65M	Buy	130,400 +47,900	+58%	+$619K	﹤0.01%	1753
2024 Q2	$1.04M	Buy	+82,500	New	+$830K	﹤0.01%	1769
2022 Q2	–	Sell	-18,500	Closed	-$1.36M	–	3042
2022 Q1	$1.36M	Buy	+18,500	New	+$1.65M	﹤0.01%	1540

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Dmitry Balyasny's NVAX Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in Novavax (NVAX) in Q2 2026: 82,240 shares worth $775K. The stake represents ﹤0.01% of the portfolio and ranks #2345 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in NVAX as recently as Q4 2025.

Dmitry Balyasny first reported a position in NVAX in Q3 2015 and has held it in 15 quarters since. The position peaked at $18M in Q2 2021. 264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Dmitry Balyasny held 82,240 shares of Novavax worth $775K as of Q2 2026.
Novavax was a new Dmitry Balyasny position in Q2 2026.
Novavax made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2345 holding.
Dmitry Balyasny first reported a position in Novavax in Q3 2015 and has held it in 15 quarters since.
Dmitry Balyasny's Novavax position peaked at $18M in Q2 2021.
264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.